Robert J. Leipold - Concepedia

Author

Robert J. Leipold

Ithaka Harbors

Also Known As

R J Leipold, R Leipold, R. Leipold, R.J. Leipold, Robert J. Leipold, Robert Leipold

Publications

348

Citations

H-Index

Concepts

All Affiliations

Ithaka Harbors Wilmington University DuPont (United States)

About

Robert J. Leipold is an author at Ithaka Harbors specializing in mechanism design, sensitivity analysis, and statistics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	1	1	28
2	Statistics	1	1	28
3	Uncertainty Quantification	1	1	28
4	Mechanism Design	1	1	28
5	Modeling And Simulation	1	1	28

Robert J. Leipold

Publications

279

Citations

H-Index

Page 1

	Year	Citations
High-level expression and purification of secreted forms of herpes simplex virus type 1 glycoprotein gD synthesized by baculovirus-infected insect cells William P. Sisk, Jodi D. Bradley, Robert J. Leipold, Journal of Virology	1994	111
Mathematical Model of Serine Protease Inhibition in the Tissue Factor Pathway to Thrombin Robert J. Leipold, Tracy A. Bozarth, Adrienne L. Racanelli, Journal of Biological Chemistry	1995	36
The effect of lomitapide on cardiovascular outcome measures in homozygous familial hypercholesterolemia: A modelling analysis Robert J. Leipold, Frederick J. Raal, Jack Ishak, European Journal of Preventive Cardiology	2017	36
Financial Implications to Medicare from Changing the Dialysis Modality Mix under the Bundled Prospective Payment System Frank X. Liu, Surrey M. Walton, Robert J. Leipold, Peritoneal Dialysis International	2014	32
On the Dangers of Adjusting the Parameter Values of Mechanism-Based Mathematical Models Joy C. Hopkins, Robert J. Leipold Journal of Theoretical Biology Mechanism DesignEngineeringModel AnalysisMechanism-based Mathematical ModelsUncertainty Quantification	1996	28
Outcomes and costs of remote patient monitoring among patients with implanted cardiac defibrillators: An economic model based on the PREDICT RM database James P. Hummel, Robert J. Leipold, Stacey L. Amorosi, Journal of Cardiovascular Electrophysiology	2019	22
Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences Tereza Lanitis, Robert J. Leipold, Melissa Hamilton, BMC Health Services Research	2017	14

Page 1